Index of reports
> Death (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Arranon (Nelarabine) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Arranon side effects in female
Reported by a physician from Japan on 2012-07-25
Patient: female, weighing 39.6 kg (87.1 pounds)
Reactions: Hepatic Function Abnormal, Hyperphosphataemia, Hyperkalaemia, Hypotension, Ventricular Arrhythmia, Acidosis, Coagulation Time Abnormal
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Arranon
Dosage: 650mgm2 per day
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-04-23
End date: 2011-04-27
Dexamethasone
Dosage: 6.6mg per day
Start date: 2011-04-28
End date: 2011-04-29
Dexamethasone
Dosage: 6.6mg per day
Indication: Neoplasm Malignant
Start date: 2011-04-20
End date: 2011-04-20
Dexamethasone
Dosage: 6.6mg per day
Start date: 2011-05-06
End date: 2011-05-06
Dexamethasone
Dosage: 13.2mg per day
Start date: 2011-04-21
End date: 2011-04-27
Other drugs received by patient: Decadron; Hydrocortisone Sodium Succinate; Sodium Bicarbonate; Pentazocine Lactate; Granisetron; Ifosfamide; Allopurinol; Fentanyl; Bosmin; Mucosta; Solita-T NO 3; Furosemide; Atarax; Potassium Chloride; Ketoprofen; Daunorubicin HCL; Fildesin; Methotrexate; Decadron; Polaramine; Diamox; Loxoprofen; Leunase; Furosemide; Seishoku; Lorcam; Platelets; Ketalar
Possible Arranon side effects in female
Reported by a physician from Japan on 2012-07-10
Patient: female, weighing 39.6 kg (87.1 pounds)
Reactions: Hepatic Function Abnormal, Hyperkalaemia, Hyperphosphataemia, Hypotension, Ventricular Arrhythmia, Acidosis, Coagulation Time Abnormal
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Arranon
Dosage: 650mgm2 per day
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-04-23
End date: 2011-04-27
Dexamethasone
Dosage: 13.2mg per day
Start date: 2011-04-21
End date: 2011-04-27
Dexamethasone
Dosage: 6.6mg per day
Start date: 2011-04-28
End date: 2011-04-29
Dexamethasone
Dosage: 6.6mg per day
Start date: 2011-05-06
End date: 2011-05-06
Dexamethasone
Dosage: 6.6mg per day
Indication: Neoplasm Malignant
Start date: 2011-04-20
End date: 2011-04-20
Other drugs received by patient: Leunase; Decadron; Solita-T; Daunorubicin HCL; Methotrexate; Mucosta; Decadron; Hydrocortisone Sodium Succinate; Furosemide; Fentanyl; Ketoprofen; Fildesin; Sodium Bicarbonate; Potassium Chloride; Pentazocine Lactate; Furosemide; Polaramine; Atarax; Bosmin; Lorcam; Ifosfamide; Allopurinol; Granisetron; Diamox; Seishoku; Platelets; Ketalar; Loxoprofen
Possible Arranon side effects in
Reported by a physician from United States on 2012-05-23
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Arranon
Possible Arranon side effects in male
Reported by a physician from Japan on 2012-03-15
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Nervous System Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Arranon
Dosage: 650mgm2 per day
Indication: Precursor T-Lymphoblastic Lymphoma / Leukaemia
Start date: 2011-02-28
End date: 2011-03-04
Arranon
Dosage: 650mgm2 per day
Start date: 2011-03-22
End date: 2011-03-26
Cytarabine
Indication: Cord Blood Transplant Therapy
Start date: 2011-02-05
End date: 2011-02-05
Cytarabine
Indication: Neoplasm Malignant
Start date: 2011-02-01
End date: 2011-02-01
Methotrexate
Start date: 2011-02-01
End date: 2011-02-02
Methotrexate
Indication: Neoplasm Malignant
Start date: 2011-02-01
End date: 2011-02-01
Vincristine Sulfate
Dosage: 2mg per day
Indication: Neoplasm Malignant
Start date: 2011-02-01
End date: 2011-02-07
Vincristine Sulfate
Dosage: 2mg per day
Start date: 2011-04-14
End date: 2011-04-21
Other drugs received by patient: Elspar; Bortezomib; Dexamethasone; Mercaptopurine; Cytarabine; Melphalan Hydrochloride; Funguard; Vfend; Etoposide; Zovirax; Cotrim; Azactam; Vicclox; Fludarabine Phosphate; Fludarabine Phosphate; Elspar; Fludarabine Phosphate; Ambisome; Zosyn; Carbenin; Fragmin; Etoposide; Doxorubicin HCL; Prednisolone; Maxipime; Tacrolimus; Targocid
Possible Arranon side effects in male
Reported by a physician from Japan on 2012-02-17
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Nervous System Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Arranon
Dosage: 650mgm2 per day
Indication: Precursor T-Lymphoblastic Lymphoma / Leukaemia
Start date: 2011-02-28
End date: 2011-03-04
Arranon
Dosage: 650mgm2 per day
Start date: 2011-03-22
End date: 2011-03-26
Bortezomib
Dosage: 1.9mg per day
Indication: Neoplasm Malignant
Start date: 2011-04-14
End date: 2011-04-24
Other drugs received by patient: Fludarabine Phosphate; Prednisolone; Funguard; Vincristine Sulfate; Melphalan Hydrochloride; Ambisome; Vfend; Carbenin; Fludarabine Phosphate; Dexamethasone; Zosyn; Azactam; Doxorubicin HCL; Elspar; Maxipime; Cytarabine; Mercaptopurine; Methotrexate; Zovirax; Vincristine Sulfate; Cytarabine; Cytarabine; Methotrexate; Fragmin; Elspar; Fludarabine Phosphate; Etoposide; Etoposide; Sulfamethoxazole; Tacrolimus; Targocid; Vicclox
Possible Arranon side effects in male
Reported by a physician from Japan on 2012-01-04
Patient: male
Reactions: Movement Disorder, Monoplegia, Muscle Atrophy, Dyspnoea, Muscular Weakness, Decreased Vibratory Sense, Hypoaesthesia, Fall, Nerve Conduction Studies Abnormal, Sensory Disturbance, Nuclear Magnetic Resonance Imaging Abnormal, Areflexia, Nervous System Disorder, Respiratory Arrest, Gait Disturbance
Adverse event resulted in: death
Drug(s) suspected as cause:
Arranon
Dosage: 650mgm2 per day
Start date: 2011-03-22
End date: 2011-03-22
Arranon
Dosage: 650mgm2 per day
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-02-28
End date: 2011-02-28
Bortezomib
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-01-01
End date: 2011-01-01
Cyclophosphamide
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-01-01
End date: 2011-01-01
Other drugs received by patient: Etoposide; Fludarabine Phosphate; Etoposide; Fludarabine Phosphate; Cytarabine; Melphalan Hydrochloride
|